Trials / Unknown
UnknownNCT06148155
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to establish and optimize the imaging method of \[68Ga\]Ga-NOTA-RG2, as well as its physiological and pathological distribution characteristics, and on this basis to evaluate the diagnostic efficacy of the above imaging agents in patients with hepatocellular carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [68Ga]Ga-NOTA-RG2 PET Imaging | Intravenous injection of 1.8 MBq \[0.05MCi\]/kg of \[68Ga\]Ga-NOTA-RG2 in a single dose. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-03-01
- Completion
- 2024-06-01
- First posted
- 2023-11-28
- Last updated
- 2024-02-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06148155. Inclusion in this directory is not an endorsement.